Auna S.A.

NYSE:AUNA

Medical - Care Facilities

Healthcare
$4.18 +1.47%

+$0.08 today

Market cap
$309.56M
Beta
0.81
P/E (TTM)
18.7
EPS (TTM)
$0.94
52W Low $4.09High $6.85

Volume 0.41M

Average 0.33M

AUNA Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Auna S.A.NYSE: AUNA

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation declines year over year

Q1 FY2026 stock-based compensation of PEN 1.93M fell 29.1% year over year, ahead of the -59.8% change in trailing-twelve-month stock-based compensation.

Context

  • Stock-based compensation amounted to 0.0% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -29.1% holds above the trailing-twelve-month pace of -59.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
PEN 1.93M— QoQ
Last fiscal yearDec 2025
PEN 0-100.0% YoY
LTMMar 2026
PEN 4.66M-59.8% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-29.1%——
1 year-100.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

PEN · from the cash flow

Latest · FY2025
0 PEN
Year-over-year change
-100.0%

Stock-Based Compensation vs competitors

How AUNA compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -59.8% is the 8th highest of 9, against a peer median of +4.1%.
  • Stock-based compensation amounts to 0.1% of revenue for AUNA, versus a peer median of 4.5%.
AUNA Competitors
Stock-Based Compensation for AUNA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AGLAgilon Health, Inc.LTM Mar 2026$38.65M USD-23.4%+20.1%0.7%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$25.13M USD-21.2%+61.0%12.1%
KIDSOrthoPediatrics Corp.LTM Mar 2026$17.9M USD+22.5%+38.6%7.4%
AUTLAutolus Therapeutics plcLTM Mar 2026$15.14M USD-5.7%+6.3%16.3%
CBLLCeriBell, Inc.LTM Mar 2026$13.6M USD+94.2%+15.5%14.3%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$7M USD+13.9%-1.1%0.7%
SNDASonida Senior Living, Inc.LTM Mar 2026$6.47M USD+35.8%+5.3%1.6%
AUNAAuna S.A.LTM Mar 2026PEN 4.66M PEN-59.8%—0.1%
TOIThe Oncology Institute, Inc.LTM Mar 2026$2.57M USD-69.9%-45.2%0.5%
Peer median (excluding AUNA) —+4.1%+10.9%4.5%

Competitors are the stored peer set for AUNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

PEN
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(23.02M)(76.83M)(214.34M)123.96M92.01M
Depreciation & Amortization77.4M138.09M235.75M219.15M209.67M
Deferred Income Tax19.9M29.38M90.17M59.82M0
Stock-Based Compensation003.68M9.15M0
Change in Working Capital49.03M(174.07M)(140.45M)(172.57M)(49.07M)
Accounts Receivables(39.47M)(80.48M)(316M)(343.15M)(76.95M)
Inventory(10.78M)(22.91M)(30.11M)(25.85M)(16.82M)
Accounts Payables000060.9M
Other Working Capital99.28M(70.68M)205.66M196.43M(16.2M)
Other Non-Cash Items60.05M246.07M607.61M429M(9.78M)
Operating Cash Flow183.34M162.64M582.41M668.5M242.83M
Capital Expenditures(289.37M)(151.97M)(165.17M)(90.86M)(81.08M)
Acquisitions (Net)(3.91M)(2.95B)(96.14M)(47.17M)6.13M
Purchases of Investments00(22.25M)00
Sales of Investments000071.34M
Other Investing Activities(54.83M)(153.83M)61.48M(98.79M)(19.93M)
Investing Cash Flow(291.99M)(3.21B)(173.15M)(236.82M)(78.83M)
Debt Repayment3.08M1.91B308.02M68.27M31.38M
Common Stock Issued0001.27B0
Common Stock Repurchased00000
Dividends Paid0(131K)(6.84M)(1.15M)0
Other Financing Activities(105.21M)1.22B(671.18M)(1.75B)(105.68M)
Financing Cash Flow(102.13M)3.13B(370M)(418.12M)(74.31M)
Effect of Forex Changes6.1M(14.07M)(6.82M)(18.95M)34.74M
Net Change in Cash(204.68M)69.92M32.44M(5.39M)124.43M
Free Cash Flow(106.03M)10.67M417.25M577.64M161.76M

Auna S.A.

NYSE:AUNA

Intrinsic Alpha fair value

Locked

Current Price

$4.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.